Geriatrik Hasta Takibi
Özet
Dünyada yaşlı nüfusun hızla artışı, kanser vakalarının büyük kısmının 65 yaş ve üzeri bireylerde görülmesine yol açmaktadır. Geriatrik kanser hastalarının takibi, genç hastalara kıyasla daha fazla özen ve bireyselleştirme gerektiren bir süreçtir. Bu hasta grubunda fizyolojik rezervlerin azalması, komorbid hastalıklar, polifarmasi ve fonksiyonel ve kognitif bozukluklar, kanser tedavi süreçlerini ve takip protokollerini karmaşık hale getirir. Bu nedenle kapsamlı geriatrik değerlendirme (CGA), fonksiyonel kapasite, beslenme, kognitif durum, psikolojik durum, komorbiditeler ve sosyal destek gibi parametreleri içeren çok boyutlu bir yöntem olarak ön plana çıkmaktadır.
Geriatrik değerlendirme sonuçlarına göre hastalar fit, hassas ve kırılgan olarak sınıflandırılır ve bu sınıflandırma, tedavi planlamasında ve toksisite yönetiminde önemli rol oynar. Özellikle kırılgan hastalarda, yaşam kalitesini ve fonksiyonelliği koruyacak düşük toksisiteli veya palyatif yaklaşımlar tercih edilir. Sistemik onkolojik tedaviler, radyoterapi, cerrahi gibi tedavi seçenekleri, yaşlı hastaların bireysel klinik özelliklerine göre dikkatlice değerlendirilerek uygulanmalıdır.
Takip süreçlerinde sadece hastalığın nüksü değil, fonksiyonel kapasite, ilaç kullanımı, yaşam kalitesi ve semptom yönetimi de düzenli olarak değerlendirilmelidir. Yaşam kalitesinin korunması ve palyatif bakım entegrasyonu, geriatrik hastaların tedavi süreçlerinin ihmal edilemez bir parçasıdır. Bu multidisipliner yaklaşımın amacı, yaşlı kanser hastalarında klinik sonuçları iyileşmesi, hasta memnuniyetinin artması, etkin bir geriatrik onkolojik takip sağlanmasıdır.
The rapid increase in the elderly population worldwide has led to the majority of cancer cases occurring in individuals aged 65 and older. The follow-up of geriatric cancer patients requires more careful and individualized approaches compared to younger patients. Reduced physiological reserves, comorbidities, polypharmacy, and functional and cognitive impairments can complicate cancer treatment and follow-up protocols. Hence, Comprehensive Geriatric Assessment (CGA), which includes multiple dimensions such as functional capacity, nutrition, cognitive and psychological states, comorbidities, and social support, has become a crucial evaluation tool in geriatric oncology.
Based on geriatric assessment outcomes, patients are classified as fit, vulnerable, or frail, significantly influencing treatment planning and toxicity management. Particularly in frail patients, low-toxicity or palliative treatments are preferred to maintain quality of life and functionality. Systemic oncological therapies, radiotherapy, and surgical options should be carefully tailored according to individual clinical characteristics of elderly patients.
Follow-up processes should regularly evaluate not only disease recurrence but also functional capacity, medication management, quality of life, and symptom control. Preservation of quality of life and integration of palliative care constitute an indispensable component of treatment for geriatric patients. The goal of this multidisciplinary approach is to improve clinical outcomes, enhance patient satisfaction, and ensure effective geriatric oncological follow-up.
Referanslar
Wild, Christopher P., Elisabete Weiderpass, and Bernard W. Stewart. "World cancer report." Cancer research for cancer prevention. International Agency for Research on Cancer (2020).
Extermann, Martine, et al. "Use of comprehensive geriatric assessment in older cancer patients: Recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)." Critical reviews in oncology/hematology 55.3 (2005): 241-252.
Balducci, L. "Geriatric oncology: challenges for the new century." European journal of cancer 36.14 (2000): 1741-1754.
Extermann, Martine, and Arti Hurria. "Comprehensive geriatric assessment for older patients with cancer." Journal of Clinical Oncology 25.14 (2007): 1824-1831.
Dale, William, et al. "Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update." Journal of Clinical Oncology 41.26 (2023): 4293-4312.
Wildiers, H., Heeren, P., Puts, M., Topinkova, E., Janssen-Heijnen, M. L., Extermann, M.,Hurria, A. (2014). International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. Journal of clinical oncology, 32(24), 2595-2603.
Decoster, L., Van Puyvelde, K., Mohile, S., Wedding, U., Basso, U., Colloca, G., & Kenis, C. (2015). Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: An update on SIOG recommendations. Annals of Oncology, 26(2), 288–300.
Rostoft, S., O'Donovan, A., Soubeyran, P., Alibhai, S. M., & Hamaker, M. E. (2021). Geriatric assessment and management in cancer. Journal of Clinical Oncology, 39(19), 2058-2067.
Mohile, Supriya G., et al. "Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology." Journal of clinical oncology 36.22 (2018): 2326-2347.
Hurria, A., Togawa, K., Mohile, S. G., Owusu, C., Klepin, H. D., Gross, C. P., & Muss, H. B. (2011). Predicting chemotherapy toxicity in older adults with cancer: A prospective multicenter study. Journal of Clinical Oncology, 29(25), 3457–3465.
Lichtman, Stuart M., et al. "International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients—an analysis of the medical literature." Journal of clinical oncology 25.14 (2007): 1832-1843.
Luciani, Andrea et al. “Estimating the risk of chemotherapy toxicity in older patients with cancer: The role of the Vulnerable Elders Survey-13 (VES-13).” Journal of geriatric oncology vol. 6,4 (2015): 272-9.
Soubeyran P, Bellera C, Goyard J, Heitz D, Cure H, Rousselot H, et al. Validation of the G8 screening tool in geriatric oncology: The ONCODAGE project. J Clin Oncol 2011;29(15 suppl):9001.
Mi, S., Yuan, M., Wang, H., Wang, C., Chen, Y., Liang, N., ... & Zhang, J. (2023). Efficacy and adverse effects of different immunotherapy in the elderly.
Selle, Frédéric, et al. "Safety and efficacy of extended bevacizumab therapy in elderly (≥ 70 years) versus younger patients treated for newly diagnosed ovarian cancer in the international ROSiA study." International Journal of Gynecological Cancer 28.4 (2018): 729-737.
Zachariah, Babu, and Lodovico Balducci. "Radiation therapy of the older patient." Hematology/oncology clinics of North America 14.1 (2000): 131-167.
Ghignone, F., et al. "The assessment and management of older cancer patients: a SIOG surgical task force survey on surgeons' attitudes." European Journal of Surgical Oncology (EJSO) 42.2 (2016): 297-302.
Makary, Martin A., et al. "Frailty as a predictor of surgical outcomes in older patients." Journal of the American College of Surgeons 210.6 (2010): 901-908.
Giger, Ann-Kristine Weber, et al. "Predictive value of geriatric oncology screening and geriatric assessment of older patients with cancer: a randomized clinical trial protocol (PROGNOSIS-RCT)." Journal of Geriatric Oncology 13.1 (2022): 116-123.
Scotté, F., Bossi, P., Carola, E., Cudennec, T., Dielenseger, P., Gomes, F., ... & Strasser, F. (2018). Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide. Annals of Oncology, 29(8), 1718-1726.
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., & Takeda, F. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376.
Wheelwright, S., et al. "International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer." British journal of cancer 109.4 (2013): 852-858.
Overcash, Janine, et al. "Validity and reliability of the FACT-G scale for use in the older person with cancer." American journal of clinical oncology 24.6 (2001): 591-596.
Ferrell, B. R., Temel, J. S., Temin, S., Alesi, E. R., Balboni, T. A., Basch, E. M., & Smith, T. J. (2017). Integration of palliative care into standard oncology care: American Society of Clinical Oncology clinical practice guideline update. Journal of Clinical Oncology, 35(1), 96–112.
Temel, J. S., Greer, J. A., Muzikansky, A., Gallagher, E. R., Admane, S., Jackson, V. A., & Lynch, T. J. (2010). Early palliative care for patients with metastatic non–small-cell lung cancer. New England Journal of Medicine, 363(8), 733–742.
Castelo-Loureiro, Alicia, et al. "Delivering palliative and supportive care for older adults with cancer: interactions between palliative medicine and geriatrics." Cancers 15.15 (2023): 3858.
Kang, EunKyo, et al. "Early integrated palliative care in patients with advanced cancer: A randomized clinical trial." JAMA network open 7.8 (2024): e2426304-e2426304.
